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Smoking, oncogenes and human
lung cancer
A review of recent laboratory evidence linking smoking and lung cancer
C. F. ALBRECHT, E. L. THERON
Summary
Recent molecular genetic experiments conducted in
the USA and The Netherlands have isolated specific
mutations in human lung cancer cells. These data
implicate the activation of the K-ras oncogene in the
pathogenesis of adenocarcinoma of the lungs of
heavy smokers and the deletion of DNA from the
short arm of chromosome 3 in small-cell and non-
small-cell carcinoma of the lung. The implications of
these results are discussed and explained in the
light of current DNA-manipulative technology which
is now available in RSA.
S AIr Med J 1988: 73: 406-408.
Early history
The association between environmental chemicals and cancer
was made 213 years ago when Percivall Pon recorded the link
between cancer of the scrotum in chimney sweeps and cancer
of the nose in snuff-takers. l
It was not until 1915, however, that Yamagiwa and Ichikawa2
induced cancer by repeatedly applying tar to the ears of
rabbits over a period of many months. After this major
discovery a concened effon was made to identify the compo-
nents of tar that were responsible for causing the cancer. At
the time there was great enthusiasm among research workers
who were optimistic that identification of the chemicals
involved would rapidly lead to finding out how they made
cells cancerous. In retrospect it is clear that these expectations
were highly premature because the chemistry of the substances,
which turned out to be polycyclic aromatic hydrocarbons,3
specifically dibenz(a,h)anthracene and benz(a)pyrene, did not
yield the necessary information.
The next major step was the discovery by Brookes and
Lawley4 in 1964 that the carcinogenicity of six different poly-
cyclic aromatic hydrocarbons correlated with their ability to
bind to cellular DNA when they were painted onto the skin of
mice. These results and others lead workers to conclude that
specific genes in the cellular DNA were responsible for the
induction or maintenance of cancer. It seemed obvious that
these putative cancer genes could be involved in the control of
cell division and differentiation, but the identification, analysis,
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isolation and possible manipulation of them was not yet
possible. As recently as 1978, Cairns5 commented '... at
present so little is known about the control of cell growth that
there is no way of guessing when we will arrive at the
necessary understanding - it could be in the next 10 or 20
years, or not for another century'.
Discovery of oncogenes
During the last decade molecular biology has been revolu-
tionised by DNA manipulative technology. It is now possible
to identify, isolate, analyse, and modify specific genes, and also
to insert those from one organism into the genome of another.
An early result of this technological triumph was the discovery
of at least 20 genes out of the total human complement of
about 100000, that could induce cancer. These were called
oncogenes and given names such as ras, myc, erb, myb, src,
fes and fms. 6
It has been shown that in normal healthy cells oncogenes
exist as so-called proto-oncogen;::s .and are involved in the self-
regulating systems of cell growth control and differentiation;
for example, the sis proto-oncogene codes for the natural
platelet-derived growth factor that is released in fresh wounds
and stimulates cell growth in order to facilitate healing.7 Other
proto-oncogenes code for growth factor receptors in the cell
membrane or for growth signal-transducing molecules in the
cytoplasm or nucleus.
.The fundamental understanding of the molecular basis of
cancer is that normal proto-oncogenes, which are present in all
cells, can be converted into deadly cancer-causing oncogenes
by carcinogens. In the case of the ras-gene family (K-ras, N-
ras and Ha-ras), it has been found that a single nucleotide
substitution (point mutation), in codons 12, 13 or 61, can
conven the normal gene into an oncogene.8 Indeed, there is
evidence that known carcinogens can cause point mutations in
ras genes of animal tumours. 9 Point-mutated N-ras genes have
been isolated and spliced into bacterial plasmid DNA. When
this DNA is added to non-transformed mouse fibroblasts in
tissue culture as a DNA-calcium-phosphate complex, some of
the fibroblasts incorporate the oncogene and transform into
rapidly dividing, disorganised cells that can form tumours in
nude mice. We have verified these fmdings and representative
results are shown in Figs 1 and 2.
Oncogenes, lung cancer and smoking
From the present evidence it can be predicted that human
lung cancer cells should contain oncogenes - that is, struc-
turally abnormal proto-oncogenes - and that the incidence of
these genes should correlate with the exposure of the patient
to carcinogens, especially tobacco smoke.
The first evidence supporting these general predictions has
recently been presented by Rodenhuis et al. 10 They found that
the K-ras gene was activated by point mutation in codon 12 in
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Fig. 1. Demonstration of the transforming potential of oncogenes. Petri dishes were seeded with NIH 3T3 mouse fibroblasts and
exposed to 20 ",g control human DNA (left) and control DNA plus 10 ng of pBR322 bacterial plasmid containing the N-ras oncogene
(right). After 12 days of incubation, numerous fibroblasts were transformed by the oncogenic DNA and formed multilayered colonies
(right). The calcium phosphate technique for gene transfer was used.'5
Fig. 2. Demonstration of the tumorigenic potential of N-ras
oncogene-transformed NIH 3T3 mouse fibroblasts. One of the
transformed colonies shown in Fig. 1. was sub-cloned and 107
cells injected subcutaneously into nude (nu/nu) mice. Tumours
measuring about 1 cm in diameter devel!Jped within 30 days.
5 of 10 adenocarcinomas of the lung. All five patients carrying
the activated K-ras gene were 'heavy smokers', whereas two of
the patients with K-ras-negative adenocarcinoma, had never
smoked. The authors admit that their subseries of only 10
patients is too small for statistical analysis but their sophis-
ticated oncogene-detecting technology will surely stimulate
much larger cohon srudies in the near future.
Chain of molecular events
What is of imponance is that a chain of molecular events has
now been uncovered which links smoking to fundamental
genetic lesions known to cause cancer. This chain of events
can be itemised as follows: (I) tobacco is lit and inhaled; (il)
carcinogens in the smoke enter lung cells; (iil) some of the
molecules are chemically activated and bind to DNA; and (iv)
during cell division, coding mistakes occur due to steric hind-
rance caused by the bound carcinogen. Most of these mistakes
are irrelevant, but if by chance a nucleotide (such as guanine)
is incorrectly replaced with thymine in codon 12 of the K-ras
proto-oncogene, this gene becomes an uncontrolled oncogene
causing permanent growth stimulation of the lung cell.
Every step in this chain of events has now been verified. lL
should be pointed out, however, that a number of srudics have
shown that complete transformation of a normal cell into a
malignant cell involves the activation of more than one onco-
gene. II It was found that an activated ras gene together with
an activated myc gene was a potent compination causing malig-
nant transformation. Amplification of at least three myc genes
(c-myc,N-myc, and L-myc) have been shown to occur in
small-cell carcinoma cell lines. I2 It is thus quite likely that a
number of improbable mutational events need to occur in the
same lung cell before a rumour can develop and metastasise.
This could explain the 20-year lag period between the advent
of smoking and the evenrual diagnosis of lung cancer. Bearing
in mind that the average smoker inhales smoke about 400
times a day (20 cigarenes x 20 puffs), it follows that the lung
cells are exposed to about 3 million carcinogenic insults over a
period of 20 years. If the chances of a critical oncogenic
transformation occurring are 1/1000 puffs it follows that the
chances of a similar event in the same cell are 103 x 103 = 106•
In other words, it may take a million puffs before the critical
combination of oncogenes is activated. Of course by chance it
could occur earlier or later. Nevenheless it makes good sense
to stop smoking at any time because the next puff could be the
fatal one.
Discovery of the deletion of DNA in lung
cancer cells
One of the difficulties with the oncogene theory of lung cancer
is that Rodenhuis er al. 10 did not find activated ras genes in all
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the lung cancers they studied. This could mean that other
unknown, mutational events may occur in lung cells also
leading to malignant transformation.
Using an entirely different technological approach Brauch er
a/. Il have recently reponed the loss of DNA in the 3pl4-p23
segment of the shon arm of chromosome 3 in 13 of 13 patients
with small-eell carcinoma of the lung whose normal somatic
tissues were heterozygous for alleles on this chromosome.
They interpret this to mean that the loss of the DNA is
important in the origin and evolution of the tumour. The
nature of the lost DNA is unknown, but it has been suggested
that it may involve a dominant gene, the absence of which
allows a recessive oncogene to become unmasked and activated.
Such a dominant gene could be termed an anti-oncogene in
the sense that it counteracts the expression of an oncogene.
It has been speculated for a number of years that inasmuch
as cells have positive growth factors that stimulate growth,
they may also contain negative factors that inhibit growth. 14
Loss of growth control could thus result from overproduction
of positive signals or an underproduction of negative signals. A
combination of these two aberrations in the same cell could
conceivably result in a very fast growing cancer.
Conclusion
The fundamental molecular mechanisms of chemical carcino-
genesis are no longer a total mystery. The advent of DNA-
manipulative technologies has made it possible to identify,
analyse and isolate oncogenes. A chain of molecular events
leading from the inhalation of tobacco smoke to cancer cells
has been established and is most likely to be elaborated in the
near future. The unravelling of the mechanisms of chemical
carcinogenesis over the last 213 years is a tribute to human
intellect and ingenuity that is unfortunately marred by the fact
that in the case of smoking the 'experimental animals' - of
which millions have died from exposure to carcinogens -were
human beings.
We thank Dr C. Mathew for a generous gift of N-ras oncogene-
containing plasmid and NIH 3T3 mouse fibroblasts.
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